CMCER

Canadian Medical Center Co.

4021StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operating Summary
Revenue	148.23M	110.80M	100.34M	81.23M	70.64M
Cost of Revenue	104.74M	82.36M	68.80M	56.26M	45.51M
Gross Profit	43.49M	28.45M	31.54M	24.97M	25.13M
SG&A	23.82M	16.64M	9.51M	7.28M	8.45M
Operating Expenses	25.69M	17.02M	15.98M	7.88M	8.95M
Operating Income	17.81M	11.43M	15.56M	17.09M	16.19M
Interest Income	0.15M	1.83M	2.40M	0.97M	—
Interest Expense	-548.29K	-509.10K	-325.27K	-562.67K	-350.18K
Other Income/Expense	79.01K	80.62K	266.67K	245.83K	306.90K
Pretax Income	12.54M	12.89M	17.86M	17.97M	16.53M
Income Tax	2.05M	2.63M	2.15M	2.32M	2.47M
Net Income	10.50M	10.27M	15.71M	15.65M	14.06M
EBITDA	21.60M	13.43M	16.48M	19.01M	18.42M
EBIT	17.81M	11.43M	15.56M	17.09M	16.19M
EPS (Basic)	0.14	0.13	0.20	0.20	0.18
EPS (Diluted)	0.14	0.13	0.20	0.20	0.18
DPS	0.13	0.05	0.19	0.20	0.30
Margins & Efficiency
Gross Margin %	+29.3%	+25.7%	+31.4%	+30.7%	+35.6%
EBITDA Margin %	+14.6%	+12.1%	+16.4%	+23.4%	+26.1%
Net Margin %	+7.1%	+9.3%	+15.7%	+19.3%	+19.9%
Revenue & Income
Revenue	148.23M	110.80M	100.34M	81.23M	70.64M
Revenue Growth (YoY)	+33.8%	+10.4%	+23.5%	+15.0%	+10.0%
Interest & Investment Income	0.15M	1.83M	2.40M	0.97M	—
Gain (Loss) on Sale of Assets	-2.15K	-7.67K	-43.79K	-1.03K	1.45K
Gain (Loss) on Sale of Investments	-4.95M	0.07M	—	0.23M	0.38M
Expenses & Provisions
Advertising Expenses	—	—	20.54K	—	—
Cost of Revenue	104.74M	82.36M	68.80M	56.26M	45.51M
Selling, General & Admin	23.82M	16.64M	9.51M	7.28M	8.45M
Operating Expenses	25.69M	17.02M	15.98M	7.88M	8.95M
Interest Expense	-548.29K	-509.10K	-325.27K	-562.67K	-350.18K
Other Non Operating Income (Expenses)	79.01K	80.62K	266.67K	245.83K	306.90K
D&A For EBITDA	3.79M	2.00M	0.92M	1.92M	2.23M
Profitability & Returns
Gross Profit	43.49M	28.45M	31.54M	24.97M	25.13M
Gross Margin	+29.3%	+25.7%	+31.4%	+30.7%	+35.6%
EBIT	17.81M	11.43M	15.56M	17.09M	16.19M
EBIT Margin	+12.0%	+10.3%	+15.5%	+21.0%	+22.9%
EBITDA	21.60M	13.43M	16.48M	19.01M	18.42M
EBITDA Margin	+14.6%	+12.1%	+16.4%	+23.4%	+26.1%
EBT Excluding Unusual Items	17.49M	12.83M	17.91M	17.75M	16.14M
Pretax Income	12.54M	12.89M	17.86M	17.97M	16.53M
Operating Income	17.81M	11.43M	15.56M	17.09M	16.19M
Operating Margin	+12.0%	+10.3%	+15.5%	+21.0%	+22.9%
Profit Margin	+7.1%	+9.3%	+15.7%	+19.3%	+19.9%
Net Income	10.50M	10.27M	15.71M	15.65M	14.06M
Net Income to Common	10.50M	10.27M	15.71M	15.65M	14.06M
Net Income Growth	+2.2%	-34.6%	+0.4%	+11.3%	-12.9%
Income Tax Expense	2.05M	2.63M	2.15M	2.32M	2.47M
Effective Tax Rate	+16.3%	+20.4%	+12.0%	+12.9%	+14.9%
Per Share & Capital
EPS (Basic)	0.14	0.13	0.20	0.20	0.18
EPS (Diluted)	0.14	0.13	0.20	0.20	0.18
EPS Growth	+2.2%	-34.6%	+0.4%	+11.3%	-95.6%
Dividend Per Share	0.13	0.05	0.19	0.20	0.30
Shares Change (YoY)	—	—	—	—	19
Shares Outstanding (Basic)	77.00M	77.00M	77.00M	77.00M	77.00M
Shares Outstanding (Diluted)	77.00M	77.00M	77.00M	77.00M	77.00M
Dividend Growth	+160.0%	-73.7%	-5.0%	-33.3%	—
Free Cash Flow	10.52M	-3.90M	9.39M	16.43M	-0.05M
Free Cash Flow Margin	+7.1%	-3.5%	+9.4%	+20.2%	-0.1%
Free Cash Flow Per Share	0.14	-0.05	0.12	0.21	-0.00
Payout Ratio	+73.4%	+67.5%	+73.5%	+147.6%	+82.1%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operating Summary
Revenue	148.23M	110.80M	100.34M	81.23M	70.64M
Cost of Revenue	104.74M	82.36M	68.80M	56.26M	45.51M
Gross Profit	43.49M	28.45M	31.54M	24.97M	25.13M
SG&A	23.82M	16.64M	9.51M	7.28M	8.45M
Operating Expenses	25.69M	17.02M	15.98M	7.88M	8.95M
Operating Income	17.81M	11.43M	15.56M	17.09M	16.19M
Interest Income	0.15M	1.83M	2.40M	0.97M	—
Interest Expense	-548.29K	-509.10K	-325.27K	-562.67K	-350.18K
Other Income/Expense	79.01K	80.62K	266.67K	245.83K	306.90K
Pretax Income	12.54M	12.89M	17.86M	17.97M	16.53M
Income Tax	2.05M	2.63M	2.15M	2.32M	2.47M
Net Income	10.50M	10.27M	15.71M	15.65M	14.06M
EBITDA	21.60M	13.43M	16.48M	19.01M	18.42M
EBIT	17.81M	11.43M	15.56M	17.09M	16.19M
EPS (Basic)	0.14	0.13	0.20	0.20	0.18
EPS (Diluted)	0.14	0.13	0.20	0.20	0.18
DPS	0.13	0.05	0.19	0.20	0.30
Margins & Efficiency
Gross Margin %	+29.3%	+25.7%	+31.4%	+30.7%	+35.6%
EBITDA Margin %	+14.6%	+12.1%	+16.4%	+23.4%	+26.1%
Net Margin %	+7.1%	+9.3%	+15.7%	+19.3%	+19.9%
Revenue & Income
Revenue	148.23M	110.80M	100.34M	81.23M	70.64M
Revenue Growth (YoY)	+33.8%	+10.4%	+23.5%	+15.0%	+10.0%
Interest & Investment Income	0.15M	1.83M	2.40M	0.97M	—
Gain (Loss) on Sale of Assets	-2.15K	-7.67K	-43.79K	-1.03K	1.45K
Gain (Loss) on Sale of Investments	-4.95M	0.07M	—	0.23M	0.38M
Expenses & Provisions
Advertising Expenses	—	—	20.54K	—	—
Cost of Revenue	104.74M	82.36M	68.80M	56.26M	45.51M
Selling, General & Admin	23.82M	16.64M	9.51M	7.28M	8.45M
Operating Expenses	25.69M	17.02M	15.98M	7.88M	8.95M
Interest Expense	-548.29K	-509.10K	-325.27K	-562.67K	-350.18K
Other Non Operating Income (Expenses)	79.01K	80.62K	266.67K	245.83K	306.90K
D&A For EBITDA	3.79M	2.00M	0.92M	1.92M	2.23M
Profitability & Returns
Gross Profit	43.49M	28.45M	31.54M	24.97M	25.13M
Gross Margin	+29.3%	+25.7%	+31.4%	+30.7%	+35.6%
EBIT	17.81M	11.43M	15.56M	17.09M	16.19M
EBIT Margin	+12.0%	+10.3%	+15.5%	+21.0%	+22.9%
EBITDA	21.60M	13.43M	16.48M	19.01M	18.42M
EBITDA Margin	+14.6%	+12.1%	+16.4%	+23.4%	+26.1%
EBT Excluding Unusual Items	17.49M	12.83M	17.91M	17.75M	16.14M
Pretax Income	12.54M	12.89M	17.86M	17.97M	16.53M
Operating Income	17.81M	11.43M	15.56M	17.09M	16.19M
Operating Margin	+12.0%	+10.3%	+15.5%	+21.0%	+22.9%
Profit Margin	+7.1%	+9.3%	+15.7%	+19.3%	+19.9%
Net Income	10.50M	10.27M	15.71M	15.65M	14.06M
Net Income to Common	10.50M	10.27M	15.71M	15.65M	14.06M
Net Income Growth	+2.2%	-34.6%	+0.4%	+11.3%	-12.9%
Income Tax Expense	2.05M	2.63M	2.15M	2.32M	2.47M
Effective Tax Rate	+16.3%	+20.4%	+12.0%	+12.9%	+14.9%
Per Share & Capital
EPS (Basic)	0.14	0.13	0.20	0.20	0.18
EPS (Diluted)	0.14	0.13	0.20	0.20	0.18
EPS Growth	+2.2%	-34.6%	+0.4%	+11.3%	-95.6%
Dividend Per Share	0.13	0.05	0.19	0.20	0.30
Shares Change (YoY)	—	—	—	—	19
Shares Outstanding (Basic)	77.00M	77.00M	77.00M	77.00M	77.00M
Shares Outstanding (Diluted)	77.00M	77.00M	77.00M	77.00M	77.00M
Dividend Growth	+160.0%	-73.7%	-5.0%	-33.3%	—
Free Cash Flow	10.52M	-3.90M	9.39M	16.43M	-0.05M
Free Cash Flow Margin	+7.1%	-3.5%	+9.4%	+20.2%	-0.1%
Free Cash Flow Per Share	0.14	-0.05	0.12	0.21	-0.00
Payout Ratio	+73.4%	+67.5%	+73.5%	+147.6%	+82.1%